Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Myocardial Infarction

Interventions

DRUG

Dapagliflozin 10mg Tab

patients will be treated with DAPA 10 mg once daily for three months

DRUG

Placebo

patients will be treated with a placebo tab once daily for three months

Trial Locations (1)

RECRUITING

Mohammad Soliman, Shibīn al Kawm

All Listed Sponsors

lead

Mohammad Hussien Tantawy Soliman

OTHER